Key Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Cell Mol Immunol. 2012 May;9(3):237-44. doi: 10.1038/cmi.2012.7. Epub 2012 Apr 16.
In recent years, the technology of constructing chimeric mice with humanized immune systems has markedly improved. Multiple lineages of human immune cells develop in immunodeficient mice that have been transplanted with human hematopoietic stem cells. More importantly, these mice mount functional humoral and cellular immune responses upon immunization or microbial infection. Human immunodeficiency virus type I (HIV-1) can establish an infection in humanized mice, resulting in CD4(+) T-cell depletion and an accompanying nonspecific immune activation, which mimics the immunopathology in HIV-1-infected human patients. This makes humanized mice an optimal model for studying the mechanisms of HIV-1 immunopathogenesis and for developing novel immune-based therapies.
近年来,构建具有人源化免疫系统的嵌合小鼠的技术显著提高。经过人造血干细胞移植的免疫缺陷小鼠中,多种谱系的人免疫细胞得以发育。更为重要的是,这些小鼠在免疫接种或微生物感染后可产生功能性体液和细胞免疫应答。人类免疫缺陷病毒 1 型(HIV-1)可在人源化小鼠中建立感染,导致 CD4(+)T 细胞耗竭和伴随的非特异性免疫激活,这模拟了 HIV-1 感染人类患者的免疫病理学。这使得人源化小鼠成为研究 HIV-1 免疫发病机制和开发新型免疫为基础的治疗方法的理想模型。